Loading clinical trials...
Loading clinical trials...
Hereditary hemorrhagic telangiectasia (HHT) is linked to a dysregulation of angiogenesis leading to the formation of arteriovenous malformations (AVM): cutaneo-mucous telangiectasia and visceral shunt...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospices Civils de Lyon
NCT00230620 · Telangiectasia, Hereditary Hemorrhagic
NCT00230633 · Telangiectasia, Hereditary Hemorrhagic
NCT02484716 · Telangiectasia, Hereditary Hemorrhagic, Osler Rendu Disease
NCT02157987 · Telangiectasia, Hereditary Hemorrhagic
NCT00230659 · Telangiectasia, Hereditary Hemorrhagic
Hospices Civils de Lyon - Hopital Louis Pradel
Bron
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions